[PDF][PDF] Citicoline: pharmacological and clinical review, 2010 update
JJ Secades - Rev Neurol, 2011 - researchgate.net
This review is based on the previous one published in 2010–Secades JJ. Citicoline:
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …
[PDF][PDF] Citicoline: pharmacological and clinical review, 2016 update
JJ Secades - Rev Neurol, 2016 - article.imrpress.com
This review is based on the previous one published in 2010–Secades JJ. Citicoline:
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …
pharmacological and clinical review, 2010 update. Rev Neurol 2011; 52 (Suppl 2): S1-62 …
Extracellular vesicles in malaria: an agglomeration of two decades of research
T Opadokun, P Rohrbach - Malaria Journal, 2021 - Springer
Malaria is a complex parasitic disease, caused by Plasmodium spp. More than a century
after the discovery of malaria parasites, this disease continues to pose a global public health …
after the discovery of malaria parasites, this disease continues to pose a global public health …
Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches
Cerebral malaria is a severe neuropathological complication of Plasmodium falciparum
infection. It results in high mortality and post-recovery neuro-cognitive disorders in children …
infection. It results in high mortality and post-recovery neuro-cognitive disorders in children …
[HTML][HTML] Role of Citicoline in an in vitro AMD model
S Nashine, MC Kenney - Aging (Albany NY), 2020 - ncbi.nlm.nih.gov
Citicoline is the exogenous form of the nootropic, Cytidine 5'-diphosphate-choline that exerts
its neuroprotective effects in the brain as well as in the eye. The current study characterized …
its neuroprotective effects in the brain as well as in the eye. The current study characterized …
Emerging avenues for the management of cerebral malaria
N Das, P Prabhu - Journal of Pharmacy and Pharmacology, 2022 - academic.oup.com
Objectives Cerebral malaria (CM) is a lethal complication of Plasmodium falciparum
infection. The multifactorial pathogenesis of the disease involving parasitic invasion of …
infection. The multifactorial pathogenesis of the disease involving parasitic invasion of …
[HTML][HTML] Citicoline: pharmacological and clinical review, 2022 update
JJ Secades, P Gareri - Revista de Neurologia, 2022 - ncbi.nlm.nih.gov
This review is based on the previous one published in 2016 (Secades JJ. Citicoline:
pharmacological and clinical review, 2016 update. Rev Neurol 2016; 63 (Supl 3): S1-S73) …
pharmacological and clinical review, 2016 update. Rev Neurol 2016; 63 (Supl 3): S1-S73) …
Potential cerebral malaria therapy: intramuscular arteether and vitamin D co-administration
Cerebral malaria (CM) shows lethality rate of 15–25% despite effective antimalarial
chemotherapy. The effective adjunct treatment to counteract the CM pathogenesis is …
chemotherapy. The effective adjunct treatment to counteract the CM pathogenesis is …
Plausible use of citicoline as an adjuvant in central nervous system infections: A case report and review of the literature
M Habiburrahman, S Sutopo… - World Academy of …, 2024 - spandidos-publications.com
Citicoline has been widely used for the treatment of neurological conditions of the central
nervous system (CNS), and exhibit potential for infection management, providing anti …
nervous system (CNS), and exhibit potential for infection management, providing anti …
[HTML][HTML] Experimental models of microvascular immunopathology: the example of cerebral malaria
Human cerebral malaria is a severe and often lethal complication of Plasmodium falciparum
infection. Complex host and parasite interactions should the precise mechanisms involved …
infection. Complex host and parasite interactions should the precise mechanisms involved …